Abstract:Aim: The aim of this study was to examine the utility of liver function tests (LFTs) in predicting the prognosis of critically ill patients with primary pulmonary hypertension (PPH) with/without liver disease. Methods: We retrieved the Medical Information Mart for Intensive Care III (MIMIC-III) database to acquire clinical data. From the database, we recruited adult patients that were equal to or older than 18 years with primary pulmonary hypertension (PPH) discharge from intensive care unit (ICU). Then, the relationship between LFTs and duration of hospitalization and ICU stays was examined based on the Spearman correlation. The chi-square assessment was conducted to examine the correlation between LFTs and death rates. Survival curves were plotted with the aid of the Kaplan-Meier technique, and the curves were subsequently compared utilizing the log-rank test. The LFTs were identified as independent predictive variables of death according to the results of multivariable logistic regression. The specificity and sensitivity for mortality were calculated utilizing receiver operating characteristic (ROC) curves and the area under the curve (AUC). Results: In total, 198 patients satisfying the inclusion criteria were recruited, among which there were 23 patients with liver disease. Only ALB was correlated with the length of ICU stay in the total PPH group. ALB independently served as a risk variable for hospital mortality and 90-day mortality and was significantly associated with 90-day and 4-year survival rates in both total PPH and PPH without liver disease. AST was correlated with hospital mortality and 90-day survival curves in both total PPH and PPH without liver disease and independently served as a risk factor for hospital and 90-day mortality only in the total PPH group. ALT independently acted as a risk variable for hospital mortality and total bilirubin was correlated with hospital mortality in the total group. The diagnostic performance of the predictive model combining the LFTs was moderately good for the hospital, 90-day, and 4-year mortality. Both Modelı End-Stage ıLiverı Disease (MELD) score and albumin-bilirubin (ALBI) score were independent risk factors for short- and long-term prognosis. And they were also significantly associated with short- and long-term prognosis. Conclusion: Among critically ill patients with PPH and with or without liver illness, aberrant LFT was linked to short- and long-term prognoses.

Clinical Signiifcance of Liver Function in Connective Tissue Disease-related Pulmonary Arterial Hypertension

Association of ABO blood types with VWF, FⅧ and ADAMTS13 levels and disease severity in liver cirrhosis patients

The Clinical Significance of the Change of Blood-Lipid in Patients with Hepatitis B-related Cirrhosis.

Stromal derived factor 1 alpha level and the liver reserve capacity in patients with different degree of liver fibrosis

Non-ALT Biomarkers for Markedly Abnormal Liver Histology among Chinese Persistently Normal Alanine Aminotransferase-Chronic Hepatitis B Patients.

Determination of Serum Fibrosis Indexes in Patients with Chronic Hepatitis and Its Significance

Clinical analysis of 110 pulmonary arterial hypertension patients with connective tissue disease

Liver Dysfunction in Idiopathic Pulmonary Arterial Hypertension: Prevalence, Characteristics and Prognostic Significance, a Retrospective Cohort Study in China.

Relationship Between Clinical and Pathologic Findings in Patients with Chronic Liver Diseases.

Abnormal Liver Function Tests Were Related to Short- and Long-Term Prognosis in Critically Ill Patients With Primary Pulmonary Hypertension

CARDIAC AND HEPATIC DYSFUNCTION IN HYPERTENSIVE PATIENTS BY ASSOCIATION OF LIVER FIBROSIS INDICES 4 AND 5

A clinical study on respiratory function and pulmonary hemodynamics in patients with portal hypertension

Clinical Significance of Associated Determinations of Serum Hepatic Fibrosis Items and Total Bile Acid Levers for Fatty Liver Patients

Influence Factors of Serum Fibrosis Markers in Liver Fibrosis

Relationship Between Hepatic Histopathological Progression and Findings of Clinical Noninvasive Examination in Patients with Non-Viral Liver Diseases

Study on clinical effect of nursing intervention on connective tissue disease complicated with pulmonary hypertension

Relationship Between Cardiac Damage and Pulmonary Hypertension in Patients with Connective Tissue Disease

The Significance of Platelet Counter and Serum Fibronectin for Assessing the State of Liver Cirrhosis

Clinical Analysis Connective Tissue Disease Related Pulmonary Arterial Hypertension

Clinical significance of serum angiotensin-converting enzyme changes in patients with liver disease

Clinical Study on the Liver Stiffness Value Measured by FibroScan and Aspartate Transaminase-to-platelet Ratio Index for Evaluation of Hepatic Fibrosis in Patients with Chronic Hepatitis B